Effects of Teneligliptin improvement endotherial dysfunction, inflammation, coagulation and oxidative stress in patients with coronary artery disease and diabetes, pilot study(Tiramisu study).

Effects of Teneligliptin improvement endotherial dysfunction, inflammation, coagulation and oxidative stress in patients with coronary artery disease and diabetes, pilot study(Tiramisu study). - Tiramisu study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011960

Enrollment

Registered

2013-10-05

Start date

2013-10-05

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

Teneligliptin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: Type I diabetes

Design outcomes

Primary

Measure	Time frame
improvement of endothelial function	—

Secondary

Measure	Time frame
HbA1c,Glycated albumin,1.5-anhydro-D-glucitol,fasting plasma glucose, immunoreactive insulin, HOMA-IR, HOMA-beta, hs-CRP, IL-6, MCP-1, TNF-alpha Red blood cell, White blood cell, platelet, D dimer, FDP, fibrinogen, 8-OHdG, BNP, body weight	—

Countries

Japan

Contacts

Public ContactMurata Makoto

Gunma University Division of Cardiology

yarukimanmann2000@yahoo.co.jp027-220-7111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026